Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
SternAegis Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
SternAegis Ventures

SternAegis Ventures

Operating

SternAegis Ventures: Aegis Capital's corporate venture arm managing venture capital financing.

Location
New York City, NY, US
Founded
2012
Firm
Compare
Portfolio
Employees
Website

SternAegis Ventures, the corporate venture arm of Aegis Capital, focuses on venture capital financing across various sectors. The firm offers a range of services including principal investing, investment banking, merchant banking, and strategic consulting. SternAegis Ventures typically invests in early to mid-stage companies, with investment sizes varying based on the company's needs and stage.

The firm's portfolio includes notable companies such as Aerami Therapeutics, DarioHealth, and Hydrofarm. SternAegis Ventures leverages its expertise to accelerate growth and unlock value for its portfolio companies. The team of investment professionals at SternAegis Ventures provides strategic guidance and support to help drive innovation and success in their investments.

SternAegis Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments23
Current Portfolio Count14
Total Portfolio Exits2

Top Investment Stages

Series Unknown14 (66.7%)
Post Ipo Equity3 (14.3%)
Series A2 (9.5%)
Angel1 (4.8%)
Convertible Note1 (4.8%)

Stage Mix

Series Unknown 67%Post Ipo Equity 14%Series A 10%Angel 5%Convertible Note 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Laconic Infrastructure Partners logo

Laconic Infrastructure Partners

Psudo logo

Psudo

Outstanding Foods logo

Outstanding Foods

Viscient Bio logo

Viscient Bio

Hydrobuilder logo

Hydrobuilder

DarioHealth logo

DarioHealth

DermaSensor logo

DermaSensor

Aerami Therapeutics logo

Aerami Therapeutics

Hydrofarm logo

Hydrofarm

BackBeat Medical logo

BackBeat Medical

Orchestra BioMed logo

Orchestra BioMed

Helocyte logo

Helocyte

Deem logo

Deem

Armada Water Assets logo

Armada Water Assets

Globeimmune logo

Globeimmune

VivoSim Labs logo

VivoSim Labs

SternAegis Ventures - Similar Investment Firms

Sterling.VC logo

Sterling.VC

Seae Ventures logo

Seae Ventures

Vestigo Ventures logo

Vestigo Ventures

StarVest Partners logo

StarVest Partners

Aragon Ventures logo

Aragon Ventures

aragonventures.com

Hither Creek Ventures logo

Hither Creek Ventures

Two Sigma Ventures logo

Two Sigma Ventures

21Ventures logo

21Ventures

21ventures.net

Eagle Venture Fund logo

Eagle Venture Fund

R3 Venture Partners logo

R3 Venture Partners

Reign Ventures logo

Reign Ventures

reignvc.com

Earthrise Ventures logo

Earthrise Ventures

Finaventures logo

Finaventures

finaventures.com

Airbus Ventures logo

Airbus Ventures

airbusventures.vc

Acrew Capital logo

Acrew Capital

acrewcapital.com

SternAegis Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified